Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q4 2018 13F Holders as of 31 Dec 2018

Security type / class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Total 13F shares
19,797,043
Total 13F value
$51,037,773
Holder snapshot 6 signals
Share change
-343,506
SEC-reported price per share
$2.58
Number of holders
49
Value change
-$3,326,792
Number of buys
14
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,762,388

Security key

05337M104

Report period

Q4 2018

Institutions

49

Top holders

10

AVDL full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2019 Previous quarter: Q3 2018 AVADEL PHARMACEUTICALS PLC SEC filings AVADEL PHARMACEUTICALS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BRANDES INVESTMENT PARTNE...
Disclosed value leader
BRANDES INVESTMENT PARTNE...
Comparable rows
15/15
Latest evidence
30 Sep 2018
13F Lead comparable stake: 6.4% Showing 1-6 of 15 holder rows.

Quick read

BRANDES INVESTMENT PARTNERS, LP leads the comparable SEC ownership view at 6.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BRANDES INVESTMENT PARTNERS, LP's linked filing trail.
Comparable ownership Top 5
BRANDES INVESTMENT PARTNERS, LP 6.4%
Broadfin Capital, LLC 2.8%
DEERFIELD MANAGEMENT COMPANY, L.P. 2.8%
ACADIAN ASSET MANAGEMENT LLC 1.1%
BROWN CAPITAL MANAGEMENT LLC 1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BRANDES INVESTMENT PARTNERS, LP
13F
Company
13F
6.4%
$27,813,000
6,335,548 shares
 — 30 Sep 2018
Broadfin Capital, LLC
13F
Company
13F
2.8%
$12,260,000
2,792,773 shares
 — 30 Sep 2018
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
2.8%
$11,951,000
2,722,241 shares
 — 30 Sep 2018
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
1.1%
$4,917,000
1,120,215 shares
 — 30 Sep 2018
BROWN CAPITAL MANAGEMENT LLC
13F
Company
13F
1%
$4,435,000
1,010,177 shares
 — 30 Sep 2018
Tekla Capital Management LLC
13F
Company
13F
0.82%
$3,576,000
814,588 shares
 — 30 Sep 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
49
Shares
19,797,043
Rows available
49
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
63
Q4 2018 holders
49
Holder diff
-14
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 value Q4 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .